CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,557,449 | -21.1% | 475,402 | -9.3% | 0.01% | -9.1% |
| Q2 2023 | $7,043,608 | -1.4% | 524,078 | +21.7% | 0.01% | -8.3% |
| Q1 2023 | $7,142,116 | -8.1% | 430,767 | +3.1% | 0.01% | -7.7% |
| Q4 2022 | $7,772,828 | +187.9% | 417,894 | +98.5% | 0.01% | +160.0% |
| Q3 2022 | $2,700,000 | -51.0% | 210,482 | -73.2% | 0.01% | -44.4% |
| Q2 2022 | $5,506,000 | -38.4% | 785,564 | -27.1% | 0.01% | -18.2% |
| Q1 2022 | $8,938,000 | +197.5% | 1,078,251 | +143.0% | 0.01% | +266.7% |
| Q4 2021 | $3,004,000 | – | 443,729 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |